Density of upper respiratory colonization with Streptococcus pneumoniae and Its role in the diagnosis of pneumococcal pneumonia among children aged <5 5 years in the PERCH study

Autor: Baggett, HC, Watson, NL, Deloria Knoll, M, Brooks, WA, Feikin, DR, Hammitt, LL, Howie, SRC, Kotloff, KL, Levine, OS, Madhi, SA, Murdoch, DR, Scott, JAG, Thea, DM, Antonio, M, Awori, JO, Baillie, VL, DeLuca, AN, Driscoll, AJ, Duncan, J, Ebruke, BE, Goswami, D, Higdon, MM, Karron, RA, Moore, DP, Morpeth, SC, Mulindwa, JM, Park, DE, Paveenkittiporn, W, Piralam, B, Prosperi, C, Sow, SO, Tapia, MD, Zaman, K, Zeger, SL, O'Brien, KL

Publikováno v: Clinical Infectious Diseases. 64(suppl_3)

Background Previous studies suggested an association between upper airway pneumococcal colonization density and pneumococcal pneumonia, but data in children are limited. Using data from the Pneumonia Etiology Research for Child Health (PERCH) study,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::a754a8a4a97867e8da2ac50cc233891e
http://ora.ox.ac.uk/objects/uuid:

Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management.

Autor: Gallagher KE; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Awori JO; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Knoll MD; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Rhodes J; Global Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand., Higdon MM; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Hammitt LL; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Prosperi C; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Baggett HC; Global Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.; Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Brooks WA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka and Matlab, Bangladesh., Fancourt N; Menzies School of Health Research, Charles Darwin University, Darwin, Australia., Feikin DR; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Howie SRC; Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Basse, The Gambia.; Department of Paediatrics, University of Auckland, Auckland, New Zealand., Kotloff KL; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Tapia MD; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Levine OS; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Madhi SA; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Murdoch DR; Department of Pathology and Biomedical Sciences, University of Otago, Christchurch, New Zealand.; Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand., O'Brien KL; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Thea DM; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America., Baillie VL; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Ebruke BE; Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Basse, The Gambia., Kamau A; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Moore DP; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.; Department of Paediatrics & Child Health, Chris Hani Baragwanath Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa., Mwananyanda L; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America.; Right to Care-Zambia, Lusaka, Zambia., Olutunde EO; Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Basse, The Gambia., Seidenberg P; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America., Sow SO; Centre pour le Développement des Vaccins (CVD-Mali), Bamako, Mali., Thamthitiwat S; Global Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand., Scott JAG; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.

Publikováno v: PloS one [PLoS One] 2024 Mar 11; Vol. 19 (3), pp. e0297159. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).

Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.

Autor: Bobrovitz N; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Department of Critical Care Medicine, University of Calgary, Calgary, AB, Canada; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: niklas.bobrovitz@mail.utoronto.ca., Ware H; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Ma X; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, ON, Canada., Li Z; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Bioengineering, University of California, Berkeley, CA, USA., Hosseini R; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada., Cao C; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Selemon A; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Whelan M; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Premji Z; Libraries, University of Victoria, Victoria, BC, Canada., Issa H; Institute of Health Informatics, University College London, London, UK., Cheng B; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Abu Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar., Buckeridge DL; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montreal, QC, Canada., Van Kerkhove MD; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Piechotta V; Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany., Higdon MM; International Vaccine Access Center, Department of International Health, John Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Wilder-Smith A; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland; Heidelberg Institute of Global Health, University of Heidelberg, Germany., Bergeri I; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Feikin DR; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Arora RK; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Institute of Biomedical Engineering, University of Oxford, Oxford, UK., Patel MK; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Subissi L; Health Emergencies Programme, World Health Organization, Geneva, Switzerland.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 May; Vol. 23 (5), pp. 556-567. Date of Electronic Publication: 2023 Jan 18.

Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant.

Autor: Sitaras I; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. isitara1@jh.edu., Jacobsen H; Department of Viral Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Higdon MM; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Dowling WE; Coalition for Epidemic Preparedness Innovations, Washington DC, USA., Bar-Zeev N; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Deloria Knoll M; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2022 Nov 15; Vol. 7 (1), pp. 147. Date of Electronic Publication: 2022 Nov 15.

Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant.

Autor: Higdon MM; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA. Electronic address: mhigdon@jhu.edu., Baidya A; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA., Walter KK; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA., Patel MK; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Issa H; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Espié E; Coalition for Epidemic Preparedness Innovations, Oslo, Norway., Feikin DR; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Knoll MD; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Aug; Vol. 22 (8), pp. 1114-1116. Date of Electronic Publication: 2022 Jun 22.